Home / Stocks / AKTS

AKTS insider trading

Aktis Oncology, Inc. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
6
Bought · 24 mo
$114.3M
Buys · last 90 days
0 · $0
Most recent buy
2026-01-14

Cluster buy detected

4 insiders bought AKTS within a short window (2026-01-12), $114.3M in total — cluster score 55/100. Members see the buyers, the score breakdown and the chart.

See the cluster

Recent insider filings

FiledInsiderTypeSharesPriceValue
2026-01-14Foley Toddcluster
Director · 10% owner
Bought232,870$18.00$4.2M
2026-01-14EVNIN LUKEcluster
10% owner
Bought1,112,777$18.00$20.0M
2026-01-14GADICKE ANSBERTcluster
10% owner
Bought1,112,777$18.00$20.0M
2026-01-12EcoR1 Capital, LLCcluster
Director
Bought2,222,222$18.00$40.0M
2026-01-12VIDA VENTURES II-A, LLCcluster
10% owner
Bought835,000$18.00$15.0M
2026-01-12Kim Helen Susancluster
Director · 10% owner
Bought835,000$18.00$15.0M

Most active insider buyers

InsiderRoleBuysTotal bought
EcoR1 Capital, LLCDirector1$40.0M
EVNIN LUKE10% owner1$20.0M
GADICKE ANSBERT10% owner1$20.0M
VIDA VENTURES II-A, LLC10% owner1$15.0M
Kim Helen SusanDirector · 10% owner1$15.0M
Foley ToddDirector · 10% owner1$4.2M

See AKTS on the chart

Every insider buy and sell for AKTS plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.